Author:
Alderman Bryony,Hui David,Mukhopadhyay Sandip,Bouleuc Carole,Case Amy A.,Amano Koji,Crawford Gregory B.,de Feo Giulia,Sbrana Andrea,Tanco Kimberson,To Josephine,Garsed Jessica,Davis Mellar
Publisher
Springer Science and Business Media LLC
Reference46 articles.
1. World Health Organisation. Alcohol, drugs and addictive behaviours unit. Cannabis. Available from: https://www.who.int/teams/mental-health-and-substance-use/alcohol-drugs-and-addictive-behaviours/drugs-psychoactive/cannabis [Accessed 8th March 2022]
2. Bridgeman MB, Abazia DT (2017) Medicinal cannabis: history, pharmacology, and implications for the acute care setting. P T 42(3):180–188
3. Wilkie G, Sakr B, Rizack T (2016) Medical marijuana use in oncology: a review. JAMA Oncol 2(5):670–675. https://doi.org/10.1001/jamaoncol.2016.0155
4. Multinational Association of Supportive Care in Cancer, 2018. Recommendations for MASCC guideline construction and the endorsement of externally generated guidelines. Available from: https://www.mascc.org/assets/Toolbox/PoliciesForms/mascc_guideline_policy_2018.pdf [Accessed 15th January 2022]
5. Sallan SE, Zinberg NE, Frei E 3rd (1975) Antiemetic effect of delta-9-tetrahydrocannabinol in patients receiving cancer chemotherapy. N Engl J Med 293(16):795–797. https://doi.org/10.1056/NEJM197510162931603
Cited by
19 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献